OQY-3258, also known as ESG401, is an anti-TROP2 ADC currently under evaluation in three clinical trials: A Phase 1a/1b clinical trial for patients with solid tumors (NCT04892342). A Phase 3 study in ...

Ground segment technology innovator appoints new CTO to execute bold technological vision HERNDON, Va., Feb. 4, 2025 /PRNewswire/ -- ST Engineering iDirect, global leader in satellite ...

The first physical Bigface store opened in December 2024 ahead of the annual Art Basel fair and concurrent events around ... The brand's smiley logo adorns the dropped ceiling over the counter ...

Orla Mining Ltd. logo (CNW Group/Orla Mining Ltd.) At the Meeting, Shareholders approved (i) the Company's proposed acquisition of the Musselwhite Mine (the "Transaction") from Newmont Corporation ...

There are good reasons why Yelo has been recognized as Saudi Arabia's best transportation solutions provider. By making every ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of ...

EA continued, "In order to break out beyond the core audience, games need to directly connect to the evolving demands of ...

Hunter, Trooper, Scrappy and Buckaroo find zen by using Zenrelia <li /> Newly published study in a leading peer-reviewed, ...

The students wore all black with a red scarf embossed with their university logo. Their voices echoed into the Capitol ...

Newly published study in a leading peer-reviewed, international journal, Veterinary Dermatology, compares clinical outcomes between Zenrelia and Apoquel® (oclacitinib tablet) ...

The students wore all black with a red scarf embossed with their university logo. Their voices echoed into the Capitol ... the swearing-in and the various glitzy balls that follow. The concurrent ...

Hunter, Trooper, Scrappy and Buckaroo find zen by using ZenreliaNewly published study in a leading peer-reviewed, international journal, Veterinary Dermatology, compares clinical outcomes between Zenr ...